Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bara

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Thrombosis Research|February 15, 1996
Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole bloodG T Gerotziafas, L Bara, M F Bloch, et al.
Thrombosis Research|January 15, 1990
Factor VII activation and menopausal statusP Y Scarabin, C Bonithon-Kopp, L Bara, et al.
International Immunopharmacology|March 5, 2013
Steroid withdrawal and reduction of cyclosporine A under mycophenolate mofetil after heart transplantationMarion Faulhaber, Ilona Mäding, Doris Malehsa, et al.
Archives Belges = Belgisch Archief|January 1, 1989
[Determinants of fat consumption in a general population]I De Craene, G De Backer, M Kornitzer, et al.
Thrombosis and Haemostasis|September 1, 1995
Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activityP Y Scarabin, G Plu-Bureau, D Zitoun, et al.
Presse Medicale (Paris, France : 1983)|February 7, 1998
[Thrombogenicity of biomaterials in cardiovascular surgery. Methods for improving the thrombogenicity of cardiovascular prostheses]G Babatasi, L Bara, M Massetti, et al.
Journal of Clinical Pharmacology|July 1, 1988
The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mgA M Frydman, L Bara, Y Le Roux, et al.
Presse Medicale (Paris, France : 1983)|February 7, 1998
[Thombogenicity of biomaterials in cardiovascular surgery. Thrombo-protection and different types of grafts]G Babatasi, L Bara, M Massetti, et al.
Thrombosis and Haemostasis|November 1, 1995
Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopeniaI Elalamy, C Lecrubier, F Potevin, et al.
Thrombosis and Haemostasis|October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapyP Y Scarabin, G Plu-Bureau, L Bara, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Thrombosis Research|February 15, 1996
Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole bloodG T Gerotziafas, L Bara, M F Bloch, et al.
Thrombosis Research|January 15, 1990
Factor VII activation and menopausal statusP Y Scarabin, C Bonithon-Kopp, L Bara, et al.
International Immunopharmacology|March 5, 2013
Steroid withdrawal and reduction of cyclosporine A under mycophenolate mofetil after heart transplantationMarion Faulhaber, Ilona Mäding, Doris Malehsa, et al.
Archives Belges = Belgisch Archief|January 1, 1989
[Determinants of fat consumption in a general population]I De Craene, G De Backer, M Kornitzer, et al.
Thrombosis and Haemostasis|September 1, 1995
Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activityP Y Scarabin, G Plu-Bureau, D Zitoun, et al.
Presse Medicale (Paris, France : 1983)|February 7, 1998
[Thrombogenicity of biomaterials in cardiovascular surgery. Methods for improving the thrombogenicity of cardiovascular prostheses]G Babatasi, L Bara, M Massetti, et al.
Journal of Clinical Pharmacology|July 1, 1988
The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mgA M Frydman, L Bara, Y Le Roux, et al.
Presse Medicale (Paris, France : 1983)|February 7, 1998
[Thombogenicity of biomaterials in cardiovascular surgery. Thrombo-protection and different types of grafts]G Babatasi, L Bara, M Massetti, et al.
Thrombosis and Haemostasis|November 1, 1995
Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopeniaI Elalamy, C Lecrubier, F Potevin, et al.
Thrombosis and Haemostasis|October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapyP Y Scarabin, G Plu-Bureau, L Bara, et al.
Pageof 9